Course: WB 2888
CE Original Date: December 31, 2017
CE Renewal Date: December 31, 2019
CE Expiration Date: December 31, 2021
Download Printer-Friendly Version pdf icon[PDF – 462 KB]
- Chronic exposure to carbon tetrachloride (CCl4) – and sometimes acute exposure to very high concentrations – produces liver and kidney damage.
- CCl4 is highly toxic. It is reasonably anticipated to be a human carcinogen, based on sufficient evidence of carcinogenicity from studies in experimental animals.
This educational case study is one in a series of self-instructional modules designed to increase the primary care provider’s knowledge of hazardous substances in the environment. The goal of Case Studies in Environmental Medicine (CSEM) is to increase the primary care provider’s knowledge of hazardous substances in the environment and to help in the evaluation and treatment of potentially exposed patients. This CSEM focuses on carbon tetrachloride toxicity.
We gratefully acknowledge the work of the medical writers, editors, and reviewers in producing this educational resource. Contributors to this version of the “ATSDR Case Studies in Environmental Medicine: Carbon Tetrachloride Toxicity” are listed below.
Note: Each content expert for this case study has indicated that he or she has no conflict of interest that would bias the case study content.
CDC/ATSDR Author(s): Dianyi Yu, MD
CDC/ATSDR Planners: Germania Pinheiro, MD, PhD; Dianyi Yu, MD; John Doyle, MPA; Diana Cronin
CDC/ATSDR Commenters: Obaid Faroon, DVM, PhD; Kim Gehle, MD, MPH; Dan Middleton, MD; Alaina Steck, MD
In order to receive continuing education (CE) for WB2888 Case Study in Environmental Medicine: Carbon Tetrachloride Toxicity, please visit TCEO and follow these 9 Simple Steps before December 31, 2021.
Complete the activity: https://tceols.cdc.gov/
Pass the posttest at 70%
To receive free continuing education, please visit the CSEM Carbon Tetrachloride Toxicity registration page
To access the CSEM Carbon Tetrachloride Toxicity, please visit the Carbon Tetrachloride Toxicity case study pdf icon[PDF – 463 KB].
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|CMEexternal icon||The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity|
|CNEexternal icon||The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.3 contact hours.
|CEUexternal icon||The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.|
Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
This program is designed for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.5. Continuing Competency credits available are 1.5 CDC provider number 98614.
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
The state of knowledge regarding the treatment of patients potentially exposed to hazardous substances in the environment is constantly evolving and is often uncertain. In developing its educational products, ATSDR has made a diligent effort to ensure the accuracy and the currency of the presented information. ATSDR, however, makes no claim that the environmental medicine and health education resources discussed in these products comprehensively address all possible situations related to various substances. The products are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients potentially exposed to hazardous substances. The products are not a substitute for a health care provider’s professional judgment. Please interpret the environmental medicine and the health education resources in light of specific information regarding the patient and in conjunction with other medical authorities.
Use of trade names in ATSDR products is for identification purposes only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry or the U.S. Department of Health and Human Services.
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
Fees: No fees are charged for CDC’s CE activities.
U.S. Department of Health and Human Services
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Human Health Sciences
Environmental Medicine Branch